[go: up one dir, main page]

AR015718A1 - Utilizacion de inhibidores del intercambiador de sodio-hidrogeno para la preparacion de un medicamento para reducir la cardiotoxicidad de sustancias - Google Patents

Utilizacion de inhibidores del intercambiador de sodio-hidrogeno para la preparacion de un medicamento para reducir la cardiotoxicidad de sustancias

Info

Publication number
AR015718A1
AR015718A1 ARP980104391A ARP980104391A AR015718A1 AR 015718 A1 AR015718 A1 AR 015718A1 AR P980104391 A ARP980104391 A AR P980104391A AR P980104391 A ARP980104391 A AR P980104391A AR 015718 A1 AR015718 A1 AR 015718A1
Authority
AR
Argentina
Prior art keywords
substances
reduce
inhibitors
sodium
preparation
Prior art date
Application number
ARP980104391A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR015718A1 publication Critical patent/AR015718A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Utilizacion de inhibidores del intercambiador de sodio-hidrogeno encuentran aplicacion para la preparacion de un medicamento para reducir lacardiotoxicidad de sustancias, es decir, disminuir los efectos indeseados en medicina humana y en veterinaria,que parten de sustancias que, administradas deforma aguda o cronica, provocan una lesion del corazon. Los inhibidores preferidos son derivados de guanidinas, isoquinolinas y en particular el empleo decariporide que comprende la formula (I).
ARP980104391A 1997-09-04 1998-09-02 Utilizacion de inhibidores del intercambiador de sodio-hidrogeno para la preparacion de un medicamento para reducir la cardiotoxicidad de sustancias AR015718A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19738604A DE19738604A1 (de) 1997-09-04 1997-09-04 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe

Publications (1)

Publication Number Publication Date
AR015718A1 true AR015718A1 (es) 2001-05-16

Family

ID=7841131

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104391A AR015718A1 (es) 1997-09-04 1998-09-02 Utilizacion de inhibidores del intercambiador de sodio-hidrogeno para la preparacion de un medicamento para reducir la cardiotoxicidad de sustancias

Country Status (23)

Country Link
US (1) US6462024B1 (es)
EP (1) EP0916337A3 (es)
JP (1) JP4555409B2 (es)
KR (1) KR19990029520A (es)
CN (1) CN1195508C (es)
AR (1) AR015718A1 (es)
AU (1) AU753899B2 (es)
BR (1) BR9803319A (es)
CA (1) CA2246633A1 (es)
CZ (1) CZ280898A3 (es)
DE (1) DE19738604A1 (es)
HK (1) HK1018212A1 (es)
HR (1) HRP980488A2 (es)
HU (1) HUP9802005A3 (es)
IL (1) IL126068A0 (es)
NO (1) NO984071L (es)
NZ (1) NZ331682A (es)
PL (1) PL328366A1 (es)
RU (1) RU2252754C2 (es)
SK (1) SK121198A3 (es)
TR (1) TR199801728A2 (es)
TW (1) TW592693B (es)
ZA (1) ZA988066B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
ES2310725T3 (es) * 2003-05-06 2009-01-16 Merck Patent Gmbh Procedimiento para la cristalizacion de sales de guanidinio.
CN112107568B (zh) * 2019-06-19 2022-03-25 北京龙嘉博创医药科技有限公司 二芳基酰胺类化合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4127026A1 (de) * 1991-08-16 1993-02-18 Boehringer Ingelheim Kg Neue pyrazinderivate, ihre herstellung und verwendung
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
TW250479B (es) * 1992-12-15 1995-07-01 Hoechst Ag
DE4337609A1 (de) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4428480A1 (de) * 1994-08-11 1996-03-07 Hoechst Ag Substituierte Benzoesäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Synthese von Inhibitoren des zellulären Na·+·/H·+·-Austauschs
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4441880A1 (de) * 1994-11-24 1996-05-30 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten

Also Published As

Publication number Publication date
ZA988066B (en) 1999-03-11
HK1018212A1 (en) 1999-12-17
TR199801728A2 (xx) 1999-04-21
CN1195508C (zh) 2005-04-06
SK121198A3 (en) 1999-03-12
KR19990029520A (ko) 1999-04-26
TW592693B (en) 2004-06-21
HU9802005D0 (en) 1998-11-30
NZ331682A (en) 2001-08-31
NO984071L (no) 1999-03-05
HUP9802005A2 (hu) 1999-04-28
IL126068A0 (en) 1999-05-09
CA2246633A1 (en) 1999-03-04
EP0916337A2 (de) 1999-05-19
CZ280898A3 (cs) 1999-03-17
AU8307398A (en) 1999-03-18
DE19738604A1 (de) 1999-03-11
AU753899B2 (en) 2002-10-31
BR9803319A (pt) 2000-03-21
EP0916337A3 (de) 2004-03-17
PL328366A1 (en) 1999-03-15
RU2252754C2 (ru) 2005-05-27
HRP980488A2 (en) 1999-06-30
HUP9802005A3 (en) 2005-06-28
CN1209995A (zh) 1999-03-10
NO984071D0 (no) 1998-09-04
US6462024B1 (en) 2002-10-08
JPH11180896A (ja) 1999-07-06
JP4555409B2 (ja) 2010-09-29

Similar Documents

Publication Publication Date Title
MX9300904A (es) Composiciones que contienen acido hialuronico
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
AR029174A1 (es) Derivados de espirooxindol, proceso para su preparacion, formulacion farmaceutica, y utilizacion de los derivados en la manufactura de medicamentos
MX9300905A (es) Tratamiento de enfermedad que emplea acido hialuronico y agentes anti-inflamatorios no esteroidales
AR009849A1 (es) Compuestos estilbenicos de grupo adamantil, composiciones que los contienen y utilizaciones
ES2114562T3 (es) Forma de dosificacion para distribucion retardada de farmacos.
BR0109446A (pt) Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
AR029403A1 (es) Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento
ES2171933T3 (es) Derivados de androsteno.
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
AR010399A1 (es) DERIVADOS DE AMIDAS DE LOS ÁCIDOS ISOXAZoLICO Y CROToNICO , PROCEDIMIENTO PARA SU PREPARACIoN MEDICAMENTO QUE LOS CONTIENE Y SU UTILIZACIoN COMO MEDICAMENTOS Y COMO AGENTES DE DIAGNoSTICO
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AR015718A1 (es) Utilizacion de inhibidores del intercambiador de sodio-hidrogeno para la preparacion de un medicamento para reducir la cardiotoxicidad de sustancias
PT97300A (pt) Processo para a preparacao de esteres de acidos 1,4-di-hidropiridinocarboxilicos n-alquilados e de medicamentos que os contem
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
AR029637A1 (es) Compuestos de guanidina, antagonistas de los receptores de la il-8, una composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de un medicamento
ES2177671T3 (es) Benzamida enterocinetica.
AR025030A1 (es) Utilizacion de flupirtina para aliviar los dolores en las artropatias degenerativas en perros y gatos para la preparacion de un medicamento para eltratamiento de dichas afecciones
ES2184424T3 (es) Nuevos compuestos heteroetinilenos y composiciones farmaceuticas y cosmeticas que los contienen.
US5760052A (en) Composition for use as a fungistat and for the treatment of fungal infections
KR950702413A (ko) 암치료에 2-(4-(4-클로로페닐)시클로헥실)-3-히드록시-1, 4-나프토퀴논을 사용하는 방법(use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer)
ATE177638T1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir

Legal Events

Date Code Title Description
FB Suspension of granting procedure